| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.6 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |